British Society for Paediatric Dermatology

British Society for Paediatric Dermatology

Search
Skip to content
  • Home
  • About Us
    • About the BSPD
    • Meet the Team
    • Membership
    • Committee Area
  • Meetings
    • Upcoming Meetings
    • Meeting Archive
  • Training
    • Courses
    • Fellowships
  • Healthcare Professional Pages
    • Clinical Guidance
      • General Paediatric Dermatology
      • Genodermatoses
      • Eczema and Allergy
      • Neonatal Dermatology
      • Vascular Anomolies
    • Adolescent Dermatology Resources
    • Fellowships / Jobs
    • Evidence-based dermatology
    • The Global Baby Skincare Initiative
    • Published Guidelines
    • NICE atopic eczema quality standard
    • Professional Societies
    • Research
  • For the Public
    • Patient information leaflets
    • Patient support groups
  • Adolescence
  • History of Paediatric Dermatology
  • BSPD Newsletters

For patients <16 who give assent, BADBIR will accept registration on any systemic used to treat psoriasis.

Aside 19th July 2019 Conor Broderick

Share this:

  • Click to share on Twitter (Opens in new window)
  • Share on Facebook (Opens in new window)
  • Click to share on Google+ (Opens in new window)

Post navigation

Previous PostFinal Programme for 2-3rd Oct Annual Meeting now released…

RSS Whats New in Paediatric Dermatology?

  • Patient‐reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross‐sectional survey 13th September 2021
  • Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events 13th September 2021
  • A case of disseminated Lyme disease in a child with skin of color 13th September 2021
  • Successful treatment of a 3‐year‐old girl with generalized pustular psoriasis using secukinumab monotherapy 13th September 2021
  • Melanocytic nevi on the hyponychium with dermoscopic features of longitudinal brush pigmentation in children 13th September 2021
  • Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza A 13th September 2021
  • Analysis of over‐the‐counter products marketed to treat molluscum contagiosum 13th September 2021
  • Disseminated and recurrent infundibulofolliculitis in children in Mexico 13th September 2021

RSS Up to Date Clinical Evidence

  • The CEBD-EVIDENCE-UPDATES list is now retained (closed).

Paediatric Dermatology In UK and Ireland

Recent Posts

  • For patients <16 who give assent, BADBIR will accept registration on any systemic used to treat psoriasis.

Our Social Media SItes

  • View BritishSocietyforPaediatricDermatology’s profile on Facebook
  • View @BSPD1’s profile on Twitter

Tweets:

My Tweets

Clinical Shortcuts

  • Eczema and Allergy
  • General Paediatric Dermatology
  • Genodermatoses
  • Neonatal Dermatology
  • Patient Information Leaflets
  • Published Guidelines
  • Vascular Anomolies
BNF for Children

Disclaimer

The BSPD regrets that it cannot answer individual patient enquiries.

Copyright

The information posted on this website is copyrighted by the British Society for Pediatric Dermatology (BSPD). No part of these pages may be reproduced in any form without the prior written permission of the BSPD.

Legal disclaimer

This site exists to provide general information about the BSPD. Although great care has been taken in developing and checking the information provided to ensure its accuracy, the BSPD, the authors, their employers, any sponsors, their servants or agents shall not be responsible or in any way liable for any errors, omissions or inaccuracies whether arising from negligence or otherwise, or for any consequences arising there from.

External links

These are provided as a courtesy only; the BSPD is not responsible for the content of external pages.

Proudly powered by WordPress